VCG
ZBH icon

Vantage Consulting Group’s Zimmer Biomet ZBH Stock Holding History

Vantage Consulting Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-430
Closed -$64K – 1618
2020
Q4 		$64K Buy
+430
New +$60.7K 0.01% 361

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vantage Consulting Group's ZBH Position: Q1 2021 in Review

Vantage Consulting Group sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 430 shares — an estimated $64K sold.

Vantage Consulting Group first reported a position in ZBH in Q4 2020 and held it in 1 quarter. The position peaked at $64K in Q4 2020. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Vantage Consulting Group reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 430 Zimmer Biomet shares in Q1 2021, an estimated $64K.
  • Vantage Consulting Group first reported a position in Zimmer Biomet in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Zimmer Biomet position peaked at $64K in Q4 2020.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.